Stereoselective Pharmacokinetics of Bisoprolol After Intravenous and Oral Administration in Beagle Dogs

作者: Yuji Horikiri , Takehiko Suzuki , Masakazu Mizobe

DOI: 10.1021/JS960453V

关键词:

摘要: The stereoselective pharmacokinetics of bisoprolol, a highly β1-selective adrenoceptor blocking agent, was studied in dogs. After intravenous and oral administration the racemate, there difference plasma concentration between S(−)- R(+)-bisoprolol. area under curve (AUC) versus time S(−)-bisoprolol ∼1.5 times higher than that R(+)-bisoprolol, elimination half–life ∼1.4 longer However, no differences were observed volume distribution, absolute bioavailability, renal clearance two enantiomers. protein binding also same as R(−)-isomer. No chiral inversion or enantiomer–enantiomer interaction observed, when enantiomers solely administered via route. comparison oxidative metabolic rate using dog liver microsomes demonstrated metabolite more slowly formed from Consequently, we concluded R(+)-bisoprolol caused disposition bisoprolol

参考文章(21)
Takehiko Suzuki, Yuji Horikiri, Masakazu Mizobe, Kazuo Noda, Sensitive determination of bisoprolol enantiomers in plasma and urine by high-performance liquid chromatography using fluorescence detection, and application to preliminary study in humans Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 619, pp. 267- 273 ,(1993) , 10.1016/0378-4347(93)80116-L
Atanu Dutta, Robert Lanc, Evan Begg, Richard Robson, Luisa Sia, Gary Dukart, Robert Desjardins, Avraham Yacobi, Dose proportionality of bisoprolol enantiomers in humans after oral administration of the racemate. The Journal of Clinical Pharmacology. ,vol. 34, pp. 829- 836 ,(1994) , 10.1002/J.1552-4604.1994.TB02047.X
P H Hsyu, K M Giacomini, Stereoselective renal clearance of pindolol in humans. Journal of Clinical Investigation. ,vol. 76, pp. 1720- 1726 ,(1985) , 10.1172/JCI112161
H.-J. Schliep, J. Harting, Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs. Journal of Cardiovascular Pharmacology. ,vol. 6, pp. 1156- 1160 ,(1984) , 10.1097/00005344-198406060-00024
G. Haeusler, H.-J. Schliep, P. Schelling, K. H. Becker, M. Klockow, K. O. Minck, H. J. Enenkel, E. Schulze, R. Bergmann, C.-J. Schmitges, C. Seyfried, J. Harting, High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol. Journal of Cardiovascular Pharmacology. ,vol. 8, ,(1985) , 10.1097/00005344-198511001-00002
M S Lennard, G T Tucker, J H Silas, S Freestone, L E Ramsay, H F Woods, Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers Clinical Pharmacology & Therapeutics. ,vol. 34, pp. 732- 737 ,(1983) , 10.1038/CLPT.1983.242
Everhardus J Ariëns, Eveline W Wuis, Bias in pharmacokinetics and clinical pharmacology. Clinical Pharmacology & Therapeutics. ,vol. 42, pp. 361- 363 ,(1987) , 10.1038/CLPT.1987.163
W. Kirch, I. Rose, H.G. Demers, G. Leopold, J. Pabst, E.E. Ohnhaus, Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease. Clinical Pharmacokinectics. ,vol. 13, pp. 110- 117 ,(1987) , 10.2165/00003088-198713020-00003
Edmund J.D. Lee, Ken M. Williams, Chirality. Clinical pharmacokinetic and pharmacodynamic considerations. Clinical Pharmacokinectics. ,vol. 18, pp. 339- 345 ,(1990) , 10.2165/00003088-199018050-00001
F. Jamali, R. Mehvar, F.M. Pasutto, Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls Journal of Pharmaceutical Sciences. ,vol. 78, pp. 695- 715 ,(1989) , 10.1002/JPS.2600780902